Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A12835 | 30261763 | Expert Rev Gastroenterol Hepatol | An update on the recent advances in antifibrotic therapy. | 2018 | Details |
A12841 | 30259536 | Hepatology | Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A12845 | 30258096 | Lab Invest | Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis. | 2018 | Details |
A12846 | 30258086 | Exp Mol Med | Role of miR-223 in the pathophysiology of liver diseases. | 2018 | Details |
A12849 | 30257633 | Med J Aust | The gut microbiota: cause and cure of gut diseases. | 2018 | Details |
A12861 | 30252139 | Lipids | Folic Acid Supplementation Attenuates Chronic Hepatic Inflammation in High-Fat Diet Fed Mice. | 2018 | Details |
A12866 | 30249972 | Diseases | The Role of Vitamin E in the Treatment of NAFLD. | 2018 | Details |
A12877 | 30246507 | Helicobacter | Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma? | 2018 | Details |
A12886 | 30241896 | Cytokine | Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity. | 2018 | Details |
A12891 | 30239004 | J Cell Physiol | Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. | 2018 | Details |
A12895 | 30236852 | Biomed Pharmacother | Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet. | 2018 | Details |
A12896 | 30235843 | Medicines (Basel) | Effects of Shugan-Jianpi Recipe on the Expression of the p38 MAPK/NF-κB Signaling Pathway in the Hepatocytes of NAFLD Rats. | 2018 | Details |
A12897 | 30235828 | Nutrients | Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern. | 2018 | Details |
A12903 | 30233587 | Front Immunol | Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization. | 2018 | Details |
A12905 | 30231595 | Nutrients | Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol. | 2018 | Details |
A12909 | 30230967 | Annu Rev Pathol | Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. | 2018 | Details |
A12923 | 30225267 | J Diabetes Res | Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats. | 2018 | Details |
A12928 | 30221912 | Minerva Med | Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study. | 2018 | Details |
A12929 | 30221732 | Mol Med Rep | Inhibition of CCL19 benefits non‑alcoholic fatty liver disease by inhibiting TLR4/NF‑κB‑p65 signaling. | 2018 | Details |
A12933 | 30219279 | J Control Release | Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
A12934 | 30219068 | Lipids Health Dis | Localization of fat depots and cardiovascular risk. | 2018 | Details |
A12936 | 30218679 | J Hepatol | MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway. | 2018 | Details |
A12939 | 30217048 | Nutrients | Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD. | 2018 | Details |
A12947 | 30213555 | Gastroenterology | Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. | 2018 | Details |
A12949 | 30213101 | Int J Mol Sci | NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation. | 2018 | Details |
A12963 | 30206707 | Amino Acids | Regulation of glucose and lipid metabolism by the pancreatic and extra-pancreatic actions of taurine. | 2018 | Details |
A12964 | 30206377 | Sci Rep | Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model. | 2018 | Details |
A12967 | 30205811 | BMC Med | An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease. | 2018 | Details |
A12972 | 30201879 | Diseases | Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD. | 2018 | Details |
A12975 | 30200724 | Zhongguo Zhong Yao Za Zhi | [Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota]. | 2018 | Details |
A12976 | 30200715 | Zhongguo Zhong Yao Za Zhi | [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway]. | 2018 | Details |
A12988 | 30194708 | Aliment Pharmacol Ther | Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease - a physiopathological and clinical integrated view. | 2018 | Details |
A12990 | 30193922 | J Hepatol | Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia. | 2018 | Details |
A12992 | 30192782 | PLoS One | Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial. | 2018 | Details |
A13026 | 30175257 | Anim Nutr | Inhibitory effect of blue honeysuckle extract on high-fat-diet-induced fatty liver in mice. | 2018 | Details |
A13031 | 30172659 | Clin Nutr | Marine omega-3 fatty acid supplementation in non-alcoholic fatty liver disease: Plasma proteomics in the randomized WELCOME* trial. | 2018 | Details |
A13055 | 30160281 | Food Funct | Freshwater clam extract reduces liver injury by lowering cholesterol accumulation, improving dysregulated cholesterol synthesis and alleviating inflammation in high-fat, high-cholesterol and cholic acid diet-induced steatohepatitis in mice. | 2018 | Details |
A13090 | 30142454 | Free Radic Biol Med | Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state. | 2018 | Details |
A13096 | 30140364 | Oxid Med Cell Longev | NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ. | 2018 | Details |
A13098 | 30139548 | Cytokine | The role of IFN in the development of NAFLD and NASH. | 2018 | Details |
A13102 | 30138466 | PLoS One | Correction: Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India. | 2018 | Details |
A13103 | 30137403 | J Clin Endocrinol Metab | Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD. | 2019 | Details |
A13106 | 30135638 | Cent Eur J Immunol | Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. | 2018 | Details |
A13108 | 30135326 | Biol Pharm Bull | Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation. | 2018 | Details |
A13124 | 30128963 | Curr Nutr Rep | Nutritional Ketosis for Weight Management and Reversal of Metabolic Syndrome. | 2018 | Details |
A13129 | 30125542 | Am J Pathol | Toll-Like Receptor-7 Signaling Promotes Nonalcoholic Steatohepatitis by Inhibiting Regulatory T Cells in Mice. | 2018 | Details |
A13131 | 30123057 | Int J Med Sci | Effects of Chinese Medicinal Formula BNG-1 on Phosphodiesterase 3B Expression, Hepatic Steatosis, and Insulin Resistance in High Fat Diet-induced NAFLD Mice. | 2018 | Details |
A13149 | 30114411 | Life Sci | C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis. | 2018 | Details |
A13165 | 30105078 | Evid Based Complement Alternat Med | Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway. | 2018 | Details |
A13168 | 30103942 | Cell Immunol | Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. | 2018 | Details |
A13172 | 30102772 | Hepatology | Macrophage-Specific Hypoxia-Inducible Factor-1α Contributes to Impaired Autophagic Flux in Nonalcoholic Steatohepatitis. | 2019 | Details |
A13185 | 30096384 | Life Sci | Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. | 2018 | Details |
A13186 | 30096092 | Eur J Gastroenterol Hepatol | Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot. | 2018 | Details |
A13193 | 30092591 | Cell Physiol Biochem | Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice. | 2018 | Details |
A13194 | 30091925 | J Proteome Res | Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. | 2018 | Details |
A13199 | 30089858 | Lab Invest | Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis. | 2018 | Details |
A13204 | 30086613 | Clin Mol Hepatol | Recent research trends and updates on nonalcoholic fatty liver disease. | 2018 | Details |
A13205 | 30085339 | Int J Mol Med | Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota in adults with non‑alcoholic fatty liver disease. | 2018 | Details |
A13208 | 30083134 | Front Endocrinol (Lausanne) | Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals. | 2018 | Details |
A13209 | 30083132 | Front Endocrinol (Lausanne) | Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis. | 2018 | Details |
A13237 | 30070430 | Mol Nutr Food Res | Soyasaponins Reduce Inflammation and Improve Serum Lipid Profiles and Glucose Homeostasis in High Fat Diet-Induced Obese Mice. | 2018 | Details |
A13244 | 30066228 | Infection | Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. | 2018 | Details |
A13254 | 30063256 | Hepatology | Dual-Specificity Phosphatase 9 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through ASK1 Suppression. | 2018 | Details |
A13257 | 30060948 | Biochem Biophys Res Commun | Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. | 2018 | Details |
A13261 | 30060508 | Int J Mol Sci | Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. | 2018 | Details |
A13270 | 30058778 | Hepatol Res | Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. | 2018 | Details |
A13274 | 30056271 | Redox Biol | Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy. | 2018 | Details |
A13275 | 30055803 | Biochem Biophys Res Commun | Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway. | 2018 | Details |
A13278 | 30054551 | Sci Rep | Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin. | 2018 | Details |
A13279 | 30053055 | J Clin Endocrinol Metab | CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk. | 2018 | Details |
A13300 | 30042374 | Int J Mol Sci | Silibinin Ameliorates O-GlcNAcylation and Inflammation in a Mouse Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
A13305 | 30039136 | Food Funct | trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. | 2018 | Details |
A13307 | 30038487 | Drug Des Devel Ther | Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis. | 2018 | Details |
A13312 | 30037080 | Nutrients | Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models. | 2018 | Details |
A13314 | 30036865 | Cell Physiol Biochem | Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells. | 2018 | Details |
A13315 | 30036479 | Mol Pharm | Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. | 2018 | Details |
A13317 | 30034912 | Liver Res | FOXO transcription factors in non-alcoholic fatty liver disease. | 2017 | Details |
A13318 | 30034633 | Oncotarget | Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. | 2018 | Details |
A13319 | 30033779 | Expert Rev Gastroenterol Hepatol | Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. | 2018 | Details |
A13322 | 30032465 | Sleep Breath | Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians. | 2018 | Details |
A13325 | 30030460 | Sci Rep | Uncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD. | 2018 | Details |
A13330 | 30027532 | Hepatol Int | Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells. | 2018 | Details |
A13334 | 30026731 | Front Endocrinol (Lausanne) | Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish. | 2018 | Details |
A13342 | 30024933 | PLoS One | miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling. | 2018 | Details |
A13348 | 30019185 | J Physiol Biochem | Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation. | 2018 | Details |
A13350 | 30018721 | Am J Transl Res | Activation of the CXCL16/CXCR6 pathway promotes lipid deposition in fatty livers of apolipoprotein E knockout mice and HepG2 cells. | 2018 | Details |
A13358 | 30016770 | Dig Dis | Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A13363 | 30015859 | Int J Mol Med | Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells. | 2018 | Details |
A13364 | 30015675 | Curr Opin Lipidol | Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis. | 2018 | Details |
A13370 | 30013757 | Middle East J Dig Dis | Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
A13376 | 30011790 | Int J Mol Sci | New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. | 2018 | Details |
A13381 | 30009570 | Physiol Rep | Curcumin supplementation mitigates NASH development and progression in female Wistar rats. | 2018 | Details |
A13382 | 30009361 | Folia Morphol (Warsz) | The differential effects of high-fat and high- -fructose diets on the liver of male albino rat and the proposed underlying mechanisms. | 2018 | Details |
A13384 | 30006580 | Int J Obes (Lond) | Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis. | 2018 | Details |
A13391 | 30002817 | F1000Res | Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. | 2018 | Details |
A13396 | 30001365 | PLoS One | Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India. | 2018 | Details |
A13406 | 29992631 | J Eur Acad Dermatol Venereol | Position statement for the management of comorbidities in psoriasis. | 2018 | Details |
A13415 | 29989851 | Am J Physiol Endocrinol Metab | Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro. | 2018 | Details |
A13448 | 29969718 | Free Radic Biol Med | IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells. | 2018 | Details |
A13461 | 29961332 | J Agric Food Chem | Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation. | 2018 | Details |